← Leaderboards
Rosalia Gerarda Matteo
Lpath Therapeutics, Inc.
$284,753
Attributed
$284,753
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $145.2K · FY2009–13$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$284,753 · 2
By mechanism
R43$284,753 · 2
Top collaborators
No co-investigators on record.
Most similar at Lpath Therapeutics, Inc.
Same institution · by research overlap
- Roger Allen Sabbadini$8,234,133
- Jonathan Michael Wojciak$152,724
Others in their field
Top investigators on “Angiogenic Factor”
- Gary Allen Rosenberg · University Of New Mexico$15,048,230
- David A Cheresh · Scripps Research Institute$14,523,310
- Jan E Schnitzer · Sidney Kimmel Cancer Center$13,111,719
- Martin Friedlander · Scripps Research Institute$12,803,832
- Aleksander S. Popel · Johns Hopkins University$12,792,300
- Wei Li · Tufts Medical Center$11,544,457
Research focus
Angiogenic FactorAntibodiesApoptosisApoptoticApplications GrantsAscitesBackBaseBenignBiologicalBladderBlood VesselsBrainCancer BiologyCancer CellCancer PatientCancer TherapyCell LineCell ProliferationCellsCell StromaCellular TargetingChemotherapeutic AgentAffect